CB Insights
Technology Market Intelligence
Technology Market Intelligence
Felicitex is a drug discovery company developing treatments and diagnostic assays to improve the effectiveness and long-term outcomes of treatments for the deadliest and most resistant to therapy cancers: pancreatic, colorectal, non-small cell lung, ...Show all
Company (Alive / Active)
Phone: 919-213-0025
27 Strathmore Road
Natick, 01760
Massachusetts, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Derivatives of quinoline as inhibitors of dyrk1a and/or dyrk1b kinases | Dec 20, 2017 | Mar 03, 2020 | Patent |
| Combinations for the treatment of neoplasms using quiescent cell targeting with egfr inhibitors | Apr 14, 2017 | Jun 18, 2019 | Patent |
| Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis | Apr 14, 2017 | Jun 11, 2019 | Patent |
| Combinations for the treatment of neoplasms using quiescent cell targeting with egfr inhibitors | Jun 17, 2019 | Application | |
| Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis | Jun 10, 2019 | Application |
